verified SJR 1,939 · Q1 • database Scopus / SJR & Web of Science indexed

Cancer Epidemiology Biomarkers and Prevention

United States · American Association for Can...

workspace_premium Q1 — Medicine (miscellaneous) visibility_off Single blind Peer Review lock Subscription

Cancer Epidemiology Biomarkers and Prevention

Cancer Epidemiology Biomarkers and Prevention is a journal indexed in SJR in Medicine (miscellaneous) and Oncology with an H index of 219. It is an CC BY-NC-ND Journal with a Single blind Peer Review review system The scope of the journal is focused on Oncology, Cancer, Epidemiology, Genetics, Molecular Eidemiology, Biomarkers. It has an SJR impact factor of 1,939 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,939.

Cancer Epidemiology Biomarkers and Prevention focuses its scope in these topics and keywords: cancer, breast, colorectal, hpv, diagnosis, lung, risk, late, type, association, ...

ISSN: 1055-9965

Publisher: American Association for Cancer Research Inc.

Category: Medicine (miscellaneous)

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Visit publisher site menu_book Author guidelines

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

1,939 Q1

H-index 219

Acceptance rate pie_chart

20% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

1,939

H-index

219

Docs (year)

206

Docs 3y

802

Total refs

8219

Cites 3y

2783

Citable 3y

761

Cites/Doc 2y

2.91

Ref/Doc

39.9

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Associations between Arsenic Exposure and Global Posttranslational Histone Modifications among Adults in Bangladesh

Uptake of Risk-Reducing Surgery in Unaffected Women at High Risk of Breast and Ovarian Cancer Is Risk, Age, and Time Dependent

Dichlorodiphenyldichloroethane and Polychlorinated Biphenyls: Intraindividual Changes, Correlations, and Predictors in Healthy Women from the Southeastern United States

Development and Validation of the Biobanking Attitudes and Knowledge Survey (BANKS)

Development and Validation of a New, Sensitive Immunochemical Assay for O6-Methylguanine in DNA and Its Application in a Population Study

Determinants of Prevalence, Acquisition, and Persistence of Human Papillomavirus in Healthy Mexican Military Men

Cutting Cost and Increasing Access to Colorectal Cancer Screening: Another Approach to Following the Guidelines

Confounding Effects of Hormone Replacement Therapy in Protein Biomarker Studies

Circulating Inflammation Markers and Risk of Epithelial Ovarian Cancer

Chlamydial Antibodies and Risk of Prostate Cancer

Carotenoid, Vitamin A, Vitamin C, and Vitamin E Intake and Risk of Ovarian Cancer: a Prospective Cohort Study

Cancer Disparities: Unmet Challenges in the Elimination of Disparities

SHOW MORE ARTICLES

Autoantibodies to Mesothelin in Infertility

-3 and -6 Polyunsaturated Fatty Acid Intakes and the Risk of Breast Cancer in Mexican Women: Impact of Obesity Status

Association of Metformin with Breast Cancer Incidence and Mortality in Patients with Type II Diabetes: A GRADE-Assessed Systematic Review and Meta-analysis

Association of Dietary Vitamin A, Carotenoids, and Other Antioxidants with the Risk of Ovarian Cancer

Association of Diabetes and Body Mass Index with Levels of Prostate-Specific Antigen: Implications for Correction of Prostate-Specific Antigen Cutoff Values?

Antibody Response to Merkel Cell Polyomavirus Associated with Incident Lymphoma in the Epilymph Case-Control Study in Spain

Anal Human Papillomavirus Infection in Women and Its Relationship with Cervical Infection

Allelic Imbalance in BRCA1 and BRCA2 Gene Expression and Familial Ovarian Cancer

A Prospective Study of Toenail Trace Element Levels and Risk of Skin Cancer

A Novel Quantitative Multiplex Tissue Immunoblotting for Biomarkers Predicts a Prostate Cancer Aggressive Phenotype

A Comparison of Trends in the Incidence of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma in the United States

A Comparison of the Polytomous Logistic Regression and Joint Cox Proportional Hazards Models for Evaluating Multiple Disease Subtypes in Prospective Cohort Studies

FAQs

Cancer Epidemiology Biomarkers and Prevention has an SJR of 1,939 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Cancer Epidemiology Biomarkers and Prevention is 20%.

Cancer Epidemiology Biomarkers and Prevention

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Cancer Epidemiology Biomarkers and Prevention?

What is the APC / publication cost?

What is the acceptance rate?